RGS
Click for more information
0.00% 12.0¢ regeneus ltd

Orthocell (ASX:OCC) announced the start of Phase 2 trials in...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Biotechasx
    76 Posts.
    lightbulb Created with Sketch. 5
    clock Created with Sketch.
    22/05/17
    13:35
    Post #: 24834750
    Orthocell (ASX:OCC) announced the start of Phase 2 trials in 2011... but this was never verified (http://ausbiotech2011.com.au/uploads/Orthocell.pdf)

    At this stage, the use of MSCs in Phase 2 trials seems to be only happening with RGS and MSB, indeed.
    RGS Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.